{
    "Trade/Device Name(s)": [
        "Ammonia II"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K183517",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003196"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JIF"
    ],
    "Summary Letter Date": "December 17, 2018",
    "Summary Letter Received Date": "December 18, 2018",
    "Submission Date": "December 17, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1065"
    ],
    "Regulation Name(s)": [
        "Ammonia test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Ammonia"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c systems",
        "cobas c 501"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Glutamate dehydrogenase method",
        "Absorbance measurement"
    ],
    "Methodologies": [
        "Enzymatic quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Ammonia II enzymatic assay for quantitative determination of ammonia in human plasma using glutamate dehydrogenase on Roche/Hitachi cobas c systems",
    "Indications for Use Summary": "Quantitative determination of ammonia in human plasma to aid in diagnosis and treatment of severe liver disorders, such as cirrhosis, hepatitis, and Reye's syndrome",
    "fda_folder": "Clinical Chemistry"
}